Allison Kurian, MD, MSc
Updated guidelines from the United States Preventive Services Task Force (USPSTF) on BRCA1/2
genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk for developing BRCA1/2
mutation–driven disease, according to critics of the update.
DNA-repair genes remains underused even among patients who have had those cancers more recently.
Figure 1. Updated USPSTF Guideline Leaves Out Key Populations
... to read the full story